nature of the tracer (Li et al 2012) . The fluoride accumulation in the skeleton is proportional to blood flow and the rate of bone turnover, and cases of osteoarthritis are associated with increased bone turnover (Burr 1998) .
NaF PET SUV metrics have been shown to correlate to clinical outcome, either for progression free survival (Harmon et al 2017) or overall survival (Lindgren Belal et al 2017) . Furthermore, Harmon et al showed that the heterogeneity of responses of individual lesions is highly predictive of progression free survival (Harmon et al 2016) . This suggests that assessment of NaF PET/CT on a per-lesion level may be useful for evaluating treatment efficacy. Misinterpreted false positive lesions may lead to suboptimal treatment decisions. Yet, due to the number of lesions that would need to be analyzed, this type of analysis requires automation, especially in the differentiation of malignant and benign bone disease.
Studies have shown that when using standardized uptake value (SUV) alone it is difficult to determine whether PET uptake is due to metastatic or benign disease (Cook and Fogelman 2000 , Muzahir et al 2015 , Sabbah et al 2015 . When physicians use CT to classify these regions of ambiguous uptake the specificity of NaF PET/CT can significantly increase (Even-Sapir et al 2006) . However, due to the large number of lesions in patients with bone metastases (Wang and Shen 2012) , it becomes impractical to perform lesion classification manually. Previous studies on automatic detection of osteoarthritis in CT and NaF PET/CT images were limited to only spinal disease in the form of osteophytes, even though osteoarthritis can commonly occur outside of the spine (Punzi et al 2004 , Rosen et al 2006 , Munoz et al 2013 , Yao et al 2014 , Wang et al 2016 .
This work aims to develop a method for classification of bone disease on NaF PET/CT scans of metastatic castrate resistant prostate cancer (mCRPC) patients. We compare nine machine learning techniques and assess their performance under different circumstances. We also develop a novel set of imaging features to include in our models that describe spatial probabilities of disease patterns.
Methods and materials Patients
This study included 37 mCRPC patients with evaluable disease who received PET/CT scans before the start of treatment. All patients received whole body PET/CT scans 60 min post injection of 160.2 ± 9.6 MBq of NaF. Scans at two of the sites were acquired on the Discovery VCT (GE Healthcare, Waukesha, WI) PET/CT scanner, and scans at the third site were acquired on the Gemini (Philips Healthcare, Amsterdam, Netherlands) PET/CT scanner. The acquisition time for a whole-body scan was 3 min per bed position, imaging from the top of the skull to the base of the feet. PET images were attenuation and scatter corrected. Harmonization of image reconstruction parameters was performed to allow quantitative comparisons across these sites as described previously (Jallow and Jeraj 2014, Lin et al 2016) . Images were quantitatively harmonized using a uniform phantom and the National Electrical Manufacturers Association International Electrotechnical Commission body phantom to measure recovery coefficient (RC) and signal-to-noise ratio (SNR). Reconstruction parameters, such as number of iterations, number of subsets, and post-reconstruction filter, were altered to minimized differences in RC and SNR between phantom images obtained at the different sites.
Reference labeling
A nuclear medicine physician (Physician 1) manually identified and classified each lesion within each patient. Lesions were classified on a five-point scale, including definitely benign (1), likely benign (2), equivocal (3), likely malignant (4), and definitely malignant (5). Benign lesions included spinal osteophytes, disease between joints, inflammation, and dental disease. A subset of 14 patients was analyzed by three additional nuclear medicine physicians (Physician 2-4) working together, but independently from the other nuclear medicine physician. In this subset of patients, one physician identified all of the lesions and then the other three physicians individually classified the lesions, which was followed by the determining of a consensus score. These patients were used to assess agreement between physicians and assess the impact of physician input into machine learning algorithms.
Lesion detection and ROI generation
In order to create a tool that is fully automated, automated detection of NaF PET lesions was performed using different SUV thresholds. Multiple studies assessing use of NaF for metastatic bone cancer imaging use a fixed threshold of SUV > 10 g ml −L for detecting disease (Kurdziel et al 2012 , Rohren et al 2015 . However, SUV > 10 g ml −1 thresholds often includes uptake in healthy bone, and thus a fixed threshold of SUV > 15 g ml
has been used as an alternative (Lin et al 2016 , Harmon et al 2017 . However, as these methods have either poor sensitivity or specificity for lesion detection, we included optimized bone-specific thresholds based on statistically optimized regional thresholding (SORT) (Perk et al 2018) , which uses a different threshold in each skeletal region defined from skeletal masks extracted from each patient's CT using atlas-based segmentation (Yip et al 2014) . In this method receiver operating characteristic (ROC) analysis was performed to determine statistically optimal thresholds for disease detection in each of these regions. For all detection methods, ROIs with non-specific NaF uptake that did not overlap the skeletal masks, such as the bladder and kidneys, were removed. Automated methods could result in ROIs that overlapped multiple physician identified lesions. If this overlap involved lesions were of multiple classes, manual splitting was performed. Each ROI was assigned a classification number based on whether it was detected by the physician and the classification of the physician described in table 1. A background ROI was defined as an ROI detected by a lesion detection method that was not corroborated by the physician and was labeled as class 0. (Galavis et al 2010) . The skeletal regions were converted into a categorical variable describing the general location of the lesion (described in table 2). ROIs overlapping multiple regions were assigned to the bone location containing the largest volume of the ROI. For spatial distribution features, we created population disease distribution models as a way to add a priori information about the likelihood of disease in the specific location of the ROI . The population disease distribution models were created by using a combination of articulated registration and optical-flow deformable registration to register patient's images and ROIs to a common template (Horn and Schunck 1981, Yip et al 2014) . The physician labels for each ROI were used to convert the combined template images into population disease distributions for each of the labels listed in table 1: definite metastases, likely metastases, equivocal lesions, likely benign lesions, definite benign lesions, and background ROIs. Two types of distributions were created: probability distribution of disease occurrence (each voxel was normalized by the number of patients) and probability distributions of disease classification (each voxel was normalized by the number of lesions that occurred at that location). Additional distributions were created combining definite benign with likely benign, background ROIs with benign lesions, and definite metastases with likely metastases. When using the spatial distribution features in our models, we adopted a leave-one-out approach where disease distribution models were created using all other patients. For each lesion, four features from each model were extracted: maximum, average, minimum, and standard deviation of probability distributions within the lesion.
Feature extraction

ROI classification
The six classes of ROIs were dichotomized into two groups based on physician labels to perform binary classification: 0-2 versus 4-5, 0-3 versus 4-5, 1-2 versus 4-5, 1-3 versus 4-5, 0-1 versus 5, and 1 versus 5. 10-fold cross-validation was used to split lesions into ten distinct training and testing datasets with 90% of the lesions and 10% of the lesions, respectively. Using the testing set in each fold, features with redundant information were removed using correlation analysis across the features. To select features for the model, ROC area under the curve (AUC) for predicting lesion binary classification was used as a surrogate for information gain. The feature with the highest AUC was selected to be included in the model, and if any features were highly correlated with that feature (R > 0.8), they were removed. This was done until all features were selected or removed. Then feature values were used as input into nine different machine learning algorithms: random forests (RF), Adaboost decision trees (DT), generalized linear models (GLM), neural network, k-nearest neighbors (KNN), linear discriminant analysis (LDA), DT, support vector machines (SVM), and Naive Bayes. Default algorithm hyperparameters (shown in table 3), when available, were used when comparing model performances. Algorithms were trained and assessed on a single physician's classification of lesions. In the case of neural networks, an additional 20% of the training data was held out to use as a validation set.
Model optimization
Comparisons of classification performance were made to assess the impact of various deterministic factors on the optimal algorithm's performance. We assessed choice of machine learning algorithm, lesion detection method, imaging resolution for extraction of texture, certainty levels of the ground truth by assessing which binary classification task was assessed, different physicians used for ground truth, inclusion of different feature sets, and algorithm hyper-parameters of the optimal model. The impact of image resampling was assessed by either up-sampling the PET or down-sampling the CT prior the texture feature extraction. Algorithm hyperparameters were optimized using Bayesian optimization. Another comparison was performed to determine the effects of determining the testing and training sets based on the number of patients (90% of patients in training versus 10% testing) or the number of lesions independently of patient (90% of lesions in training versus 10% testing).
Statistics
Agreement between physicians was assessed using Fleiss' κ and Cohen's weighted κ. Fleiss' κ was used to compare the agreement of Physicians 2-4, who had worked together to form a consensus, and Cohen's weighted κ was used to compare the consensus of those three physicians to Physician 1. The sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) of each classifier were determined at the classification score threshold that results in the highest summed sensitivity and specificity. A modified McNemar test (Hawass 1997 ) was used to compare the classification results of the different algorithms and determine if any algorithms had significantly better classification results than the others. Using the classification score of each algorithm, ROC AUC was assessed for each classifier. ROC curves were then tested using DeLong's test (DeLong et al 1988) , which determines if statistically significant differences exist between ROC curves. Confidence intervals of AUC, sensitivity, and specificity were obtained based on the different folds of the cross-validation, and standard error was used to determine confidence intervals of PPV and NPV.
Machine learning models were implemented in MATLAB 2017a using the machine learning toolbox and statistical comparisons of model outputs was performed in R.
Results
In the whole population of 37 patients, 1751 lesions were identified by physician. This dataset was used to train, test and compare various ML algorithms. Additionally, the subgroup of 14 patients, containing 598 lesions, were analyzed by additional three physicians to assess variability of physician classification of lesions. The physicians took in general over an hour to analyze each patient. The agreement between physicians is shown in table 4. Absolute agreement between physicians for all five classes was only 62%. Fleiss' κ between Physician 2-4 was only moderate (0.56). Agreement was higher for lesions that the physicians were more certain of (Class 1 and 5). According to Cohen's weighted κ, there was significant agreement between the Physician 1 and the consensus of Physician 2-4. 2% (12/598) of lesions were classified as definite metastasis by one physician and as definite benign by another physician. The number of ROIs identified by the physicians and by the automated lesion detection methods for all of the patients are shown in table 5. The spatial disease distributions created from the whole population are shown in figure 1. Table 6 shows the numbers of features used for each model after removing redundant features if feature selection was performed on the whole population. Table 7 lists the features selected for the SORT model, and the features for the models using the other detection methods can be found in supplementary data (stacks.iop.org/ PMB/63/225019/mmedia). Table 8 contains AUC, sensitivity, and specificity for all of the models. The ROC curves showing performance of the different machine learning algorithms when using statically optimized regional thresholding ( Figure 3 shows a comparison of the classification performance when using RF with three different lesion detection methods. SORT resulted in significantly superior lesion classification (P < 0.001) as compared with the global fixed thresholds. Classification using either of the global thresholds was comparable (P = 0.69). Table 5 shows the number of ROIs removed by the models for each identification method.
The best model performance was found when only using the classes with the highest physician certainty (class 1 versus 5, P = 0.04) and when grouping background ROIs with benign lesions (classes 0-1 versus 5, P < 0.0001). The highest performance also comes from models that use all the aforementioned features, followed by models that only exclude spatial distribution features (P = 0.7) or texture features (P = 0.018). Using the native imaging resolution when extracting texture resulted in similarly performing models as to upsampling the PET or downsampling the CT (P > 0.5). Bayesian optimization of RF hyperparameters (using the dataset segmented with SORT) identified the optimal configuration to include 1719 trees, a minimum leaf size of 1, and 17 features sampled at each node, this model did not perform better than models with suboptimal configurations (P > 0.5). Dividing up training and testing based on number of patients instead of number of lesions did not impact model performance. Figure 4 shows the ROC curve with confidence intervals for the highest performing model. Figure 5 shows classification performance of the RF model when each physician is independently used for training and testing. Models trained and testing using each physician's labels had high classification performance. In particular, models trained and tested on Physicians 2-4 had very similar algorithm performance (P > 0.7). The model predicting the labels from Physician 1 had higher sensitivity for benign diseases, but had a lower specificity; however, this was not a significant difference (P = 0.4). Additionally, the use of one physician for the training set and predicting a different physician's labels resulted in high AUCs, ranging from 0.90-0.94.
Discussion
The primary challenge for developing automated NaF PET lesion classification is subjective nature of the classification, different physicians may not classify lesions the same way. This is noticeable in our analysis, where there was only moderate agreement between physicians. While in our work lesion detection was performed by a single physician, different physicians would have different sensitivities or specificities for lesion detection, and this would further reduce the agreement between physicians. The large numbers of lesions and moderate interobserver variability in lesion classification demonstrates the need for automation in lesion classification in NaF PET/CT imaging. Ideally, biopsies or extended follow-up would be used to corroborate the physician findings, but performing biopsies on such a large number of lesions is impractical. Extended follow-up was not available for these subjects, and using extended follow-up as ground truth has its own limitations. Thus, we chose to use the combined experience of four nuclear medicine physicians as our reference. We tested nine different machine learning algorithms for lesion classification. RF were found to more accurately replicate physician classifications of benign and malignant lesions (AUC = 0.95) than other machine learning algorithms. RF had significant improvement over most models except for Adaboost DT, GLM and neural networks. This implies that there is a complex relationship between benign and malignant lesions, in which there is no feature hyperplane that can be used to cleanly separate benign lesions from malignant lesions. An alternative approach would be to use deep learning through convolutional neural networks. This would reduce the need for assessment of different features and further investigation into the use of deep learning for benign disease classification is merited.
It should be noted that hyperparameters were not investigated for all machine learning models. With default parameters RF outperformed the other models; however, while RF hyperparameters did not improve testing performance of the algorithm it is possible that hyperparameters of the other models could significantly improve the performance of those algorithms. Further investigation might be unnecessary, as it has been shown that RF models often outperform other machine learning algorithms in various tasks (Fernandez-Delgado et al 2014).
As can be noted by our training results, RF almost perfectly fit the training data in each fold of cross-validation, which would lead to a concern of overfitting. However, the models maintained high classification performance on the testing data. This is a strength of RF, which have been shown to avoid decreased testing performance, even when perfect training is achieved (Svetnik et al 2003) . We also assessed the impact of other hyperparameters as well as the number of features necessary. Each of these factors indicate that overfitting was not a concern.
Of the automatic lesion detection methods, the statically optimized regional thresholding (SORT) method resulted in a superior classification model than using the global thresholds. This is likely due to SORT's improved sensitivity and specificity for detecting disease compared to the global thresholds; it detected more disease than either global threshold while outputting fewer background ROIs than SUV > 10 g ml −1 thresholds. We focused on binary groupings for classification due to the limited numbers of equivocal, likely benign, or likely metastatic lesions (i.e. classes 2-4). Grouping background ROIs with definite benign lesions and performing binary classification of these against definite metastases (classes 0-1 versus 5) resulted in the best algorithm performance. However, the algorithm still had good performance in differentiating lesions of which physicians (class 0-2 versus 4-5) were less certain (AUC = 0.92). Likely the reduced model performance on the uncertain Figure 1. Spatial probability distributions of disease occurrence across the patient population projected onto skeleton renderings. Each voxel represents the percent of patients that had that disease throughout the population. Table 6 . Number of features from each type of feature that could be included in the models after features selection, the location feature was included in all models unless otherwise stated. PET texture Sum mean(PET), sum variance(PET), maximum probability(PET), dissimilarity(PET), sum energy(PET), run percentage(PET), short run low gray-level emphasis(PET), Coarseness(PET), contrast-NGL(PET), busyness(PET)
Detection method
CT texture Correlation(CT), inverse difference moment(CT), sum mean(CT), sum variance(CT), information measure of correlation 1(CT), dissimilarity(CT), sum energy(CT), cluster shade(CT), small run emphasis(CT), number nonuniformity(CT), second moment(CT), coarseness(CT), contrast-NGL(CT), busyness(CT)
Disease distribution Maximum(background occurrence), minimum(background occurrence), mean(background occurrence), minimum(definite metastases occurrence), mean(definite metastases classification), minimum(likely metastases occurrence), mean(likely metastases occurrence), standard deviation(likely metastases occurrence), maximum(likely metastases classification), minimum(likely metastases classification), mean(likely metastases classification), minimum(equivocal occurrence), mean(equivocal occurrence), standard deviation(equivocal occurrence), minimum(equivocal classification), mean(equivocal classification), standard deviation(equivocal classification), maximum(likely benign occurrence), minimum(likely benign occurrence), mean(likely benign occurrence), minimum(likely benign classification), mean(likely benign classification), standard deviation(likely benign classification), mean(definite benign occurrence), standard deviation(definite benign occurrence), maximum(definite benign classification), minimum(definite benign classification), mean(likely/definite metastases occurrence), standard deviation(likely/definite metastases occurrence), minimum(likely/definite metastases classification), standard deviation(likely/definite metastases classification), minimum(likely/definite benign occurrence), maximum(background/likely/definite benign occurrence), minimum(background/likely/definite benign occurrence), mean(background/ likely/definite benign occurrence), standard deviation(background/likely/definite benign occurrence), minimum(background/likely/definite benign classification), mean(background/likely/definite benign classification), standard deviation(background/likely/definite benign classification) Table 8 . Summary of model performances on the training and testing sets under different conditions, with 95% CI. In the top section machine learning models were compared and in the remaining sections, the RF model was altered by one parameter. Figure 3 . Performance statistics of random forest (RF) models trained using the different lesion identification and segmentation methods. Data resulting from using SORT thresholds resulted in a superior classification model (P < 0.05) than data resulting from the other thresholding methods.
lesions is a result of physician inconsistency. An additional benefit of grouping background ROIs with metastases is the reduction of the false positive rate of the automated lesion detection methods. Using only PET features or using only CT features resulted in worse classification performance than when using both sets of features. The highest performance was found using all of PET, CT, spatial distribution, and texture features. Interestingly, this fully inclusive model was not statistically superior to the model that included all features except the spatial distribution features. This suggests that the spatial distribution features may not be nec- essary to achieve a top performing classification model and that in cases where the model speed would be optimized these more complicated features could be excluded. Texture features appear to be another set of features that provided minimal gain to the model, even though excluding texture resulted in a significant decrease in performance. Additionally, as the impact of voxel size for extraction of image texture was minimal on the classification performance of RF (P > 0.5), the CT can be downsampled to reduce computation time of extracting texture.
An interesting trend was found when we performed cross-validation to select equal numbers of patients in each training and testing dataset rather than equal numbers of lesions. We found that the underlying patient level correlation of lesions from the same patient did not provide a significant improvement in model performance. This likely implies that the RF model did not use any patient specific information in the classification.
With the different physician classifications available to us, we were able to assess if the model performance is dependent on the physician that performed the classification. Our model had high performance on predicting how each physician classified lesions. This implies that the model is able to replicate tendencies in each physician's classification performance.
This study had several limitations. As discussed, the primary limitation is the lack of ground truth classification labels. However, as we were able to create models that could replicate the scoring tendencies of each physician, if a ground truth became available in the future, we expect the model could be trained to learn those classifications as well. Another limitation is the use of a simple lesion segmentation method. With a method that accurately determines lesion boundaries, the splitting of lesions that were merged together during lesion detection would not need to be performed and the quantification of each ROI would be more accurate. We hypothesize that this would result in superior classification performance of machine learning models. However, even the current level of performance of our algorithm exceeds any available alternative.
Conclusion
We have developed the first automated lesion classification tool for NaF PET/CT images. This tool, when combined with the automated lesion detection tool, SORT, can allow physicians to quickly and accurately classify and analyze lesions in NaF PET/CT images. We found that RF outperformed other classification algorithms when classifying lesions in NaF PET/CT images. When the model was trained and tested using classification labels from four different physicians, it maintained high classification performance for predicting each physician's labels.
